Saturday, 31 October 2026European Markets

THUNDERBIRD Stock Bullish By 28% In The Last 21 Sessions

Loading stream...

Thunderbird Resorts Inc. is witnessing a substantial mix of opportunities and challenges in the market. Recently, its shares experienced a dramatic surge of 28.57% during 21 trading sessions, moving from a value of EUR0.07 to EUR0.09 and mirroring the rise in AEX-Index values.

Company Overview

Thunderbird Resorts is a company that is focused on gaming, hospitality and real estate businesses primarily in Nicaragua and Peru. Its offerings include table and slot gaming as well as sportsbooks across its expansive estate of three slot parlors, three casinos and 630 gaming positions. Additionally, the company holds interests in real estate development projects and office rentals.

Financials

From a financial perspective, Thunderbird currently posts a trailing 12-month earnings per share (EPS) of EUR0.01, and sports a trailing PE ratio of 9.4. This signifies that investors purchasing its shares are paying EUR9.4 for every euro of annual earnings the company generates.

Trading Volume and Price Movements

Notably, Thunderbird stock trade volume was reported at 145,593, which is significantly lower than its average volume of 57706 -- potentially signaling decreased interest among traders. The volatility ratios depict notable price fluctuations; with last week at 1.95%, last month at 1.92% and a sizeable 6.86% over the last quarter denoting high levels of risk and uncertainty with regard to its share price.

Prediction Indicators

According to the stochastic oscillator, a commonly used indicator for overbought and oversold conditions, Thunderbird stock is currently considered oversold. This might signal an opportunity for investors to buy this stock at reduced prices given its possibility to rebound in the short term. However, investors should approach this with caution, especially considering its recent volatility and below average trading volume.

More news about THUNDERBIRD (TBIRD.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com